MED vs CSV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

MED

50.5
AI Score
VS
MED Wins

CSV

46.8
AI Score

Investment Advisor Scores

MED

51score
Recommendation
HOLD

CSV

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MED CSV Winner
Revenue 152.43M 106.12M MED
Net Income -5.22M 13.49M CSV
Gross Margin 69.0% 36.4% MED
Net Margin -3.4% 12.7% CSV
Operating Income -7.62M 25.28M CSV
ROE -2.7% 5.1% CSV
ROA -2.0% 1.0% CSV
Total Assets 260.40M 1.35B CSV
Cash 71.91M 2.91M MED
Current Ratio 4.86 1.15 MED
Free Cash Flow -108,000 11.00M CSV

Relative Price Performance (Last 90 Days)

MED 1M: +16.2% · 3M: +20.6% CSV 1M: +5.2% · 3M: -14.8%

Current Technical Phase

MED

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 72

RSI (14): 71.9 · Price: $12.83

CSV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.4 · Price: $40.28

Fundamentals Snapshot

Metric MED CSV
Market Cap
Forward P/E -16.5 10.8
Trailing P/E 14.7
Revenue (TTM)
Revenue Growth -0.3% 0.0%
Gross Margin 0.7% 0.4%
Operating Margin -0.1% 0.2%
EPS -1.82 2.75
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, MED is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.